期刊文献+

热休克蛋白60对小鼠树突状细胞成熟及免疫功能的影响 被引量:4

Effect of Heat Shock Protein 60 on Murine Dendritic Cell Maturation and Immunologic Function
下载PDF
导出
摘要 目的探讨动脉粥样硬化中重要炎性物质———热休克蛋白60(HSP60)体外对小鼠树突状细胞(mDC)功能的影响。方法从近交系C57BL/6J小鼠骨髓中提取mDC,体外培养成熟后分别与3、10μg/ml mHSP60或PBS孵育24 h,观察其形态改变;流式细胞仪检测mDC表面标志;混合淋巴细胞反应(MLR)测定mDC刺激功能;ELISA法测定MLR上清液中细胞因子浓度。结果mHSP60处理组较对照组,mDC突起增加明显;CD80及CD86表型显著增加;淋巴细胞刺激功能明显增强;上清液细胞因子IL-12、IFN-γ增加(P<0.01)而IL-4增加不明显(P>0.05),IFN-γ/IL-4比值升高。以上变化mHSP60高剂量处理组较低剂量处理组更明显。结论mHSP60体外可以促进mDC功能,且作用呈剂量依赖性。 Objective To investigate the effect of heat shock protein 60 (HSP60), an important inflammatory factor in atherogenesis, on the maturation of murine dendritic cells (mDCs) in vitro, Methods Myeloid mDCs were obtained in vitro from C57BL/6J mouse marrow and incubated to mature with 3 μg/ml and 10 μg/ml of mHSP60 or PBS for 24 h. The morphological changes were observed. The phenotype was detected by using flow cytometry. The stimulating capacity was determined by allogenic mixed lymphocyte reaction (MLR). ELISA was used to measure the level of cytokines in thesupernatant of MLR. Results Compared to control group, mDC showed more protrusions, the expression of CD86 and CD80 on mHSP-DC significantly up-regulated, the stimulating capacity of mHSP-DCs obviously enhanced, levels of IFN-γ in the supernatant increased. and the ratio of IFN-γ/IL-4 elevated in mHSP60-treated groups. The above changes were more significant in the high dose mHSP60-treated group than in the low dose mHSP60-treated group. Conclusion mHSP60 could promote the maturation of mDC dose-dependently in vitro.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2006年第1期46-48,55,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 日本内田国际基金资助项目
关键词 热休克蛋白60 树突状细胞 动脉粥样硬化 细胞表型 细胞因子 heat shock protein 60 dendritic cells atherosclerosis phenotype cytokines
  • 相关文献

参考文献12

  • 1BANCHEREAU J,STEINMAN R M.Dendritic cells and the control of immunity[J].Nature,1998,392(6673):245-252.
  • 2YILMAZ A,LOCHNO M,TRAEG F,et al.Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques[J].Atherosclerosis,2004,176(1):101-110.
  • 3XU Q,KIECHL S,MAYR M,et al.Association of serum antibodies to heat shock protein 65 with carotid atherosclerosis:clinical significance determined in a follow up study[J].Circulation,1999,100(11):1169-1174.
  • 4INABA K,INABA M,ROMANI N,et al.Generation of large number of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colonystimulatingfactor[J].J Exp Med,1992,176 (6):1693-1702.
  • 5BOBRYSHEV Y V,LORD R S A.Vascular-associated lymphoid tissue (VALT) involvement in aortic aneurysm[J].Atherosclerosis,2001,154(1):15 21.
  • 6SAMA R,LID Z,ZENG Q T,et al.Differentiation of dendritic cells in monocyte cultures isolated from patients with unstable angina[J].Int J Cardiol,2004,97(3):551-555.
  • 7李大主,Sharma Ranjit,曾秋棠,田园,冯义柏,王祥,曹林生.阿托伐他汀对不稳定型心绞痛患者树突状细胞功能的影响[J].中华内科杂志,2004,43(6):429-432. 被引量:21
  • 8BOBRYSHEV Y V,LOAD R S A.Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions[J].Cardiovasc Res,1998,37(3):799-810.
  • 9ZHU J,QUYYUMI A A,ROTT D,et al.Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary heart disease[J].Circulation,2001,103(8):1071-1075.
  • 10MANDAL K,JAHANGIRI M,XU Q.Autoimmunity to heat shock protein in atherosclerosis[J].Autoimmun Rev,2004,3(2):31-37.

二级参考文献10

  • 1Shah PK. Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol,2003,41(4 Suppl S):15S-22S.
  • 2Mulvihill NT, Foley JB. Inflammation in acute coronary syndromes. Heart, 2002,87:201-204.
  • 3Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature, 1998,392:245-252.
  • 4Lefer DJ. Statins as potent antiinflammatory drugs. Circulation,2002,106:2041-2042.
  • 5Hansson GK, Libby P, Schonbeck U, et al. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res,2002,91:281-291.
  • 6Bobryshev YV, Lord RS. S-100 positive cells in human arterial intima and in atherosclerotic lesions. Cardiovasc Res, 1995,29:689-696.
  • 7Biasucci LM, Liuzzo G, Grillo RL, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation, 1999,99:855-860.
  • 8Alderman CJ, Bunyard PR, Chain BM, et al. Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic micro-environment? Cardiovasc Res, 2002,55:806-819.
  • 9Kinlay S, Schwartz GG, Olsson AG, et al. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation, 2003,108:1560-1566.
  • 10Correia LC, Sposito AC, Lima JC, et al. Anti-inflammatory effect of atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction. Am J Cardiol,2003,92:298-301.

共引文献20

同被引文献83

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部